|
IQCB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.260500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.605000E-01 |
| Normal-vs-Stage2 |
4.275100E-03 |
| Normal-vs-Stage3 |
8.076400E-02 |
| Normal-vs-Stage4 |
2.308200E-01 |
| Stage1-vs-Stage2 |
6.943500E-03 |
| Stage1-vs-Stage3 |
3.251800E-01 |
| Stage1-vs-Stage4 |
7.248200E-01 |
| Stage2-vs-Stage3 |
7.773600E-02 |
| Stage2-vs-Stage4 |
5.024400E-02 |
| Stage3-vs-Stage4 |
6.326000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.892240E-01 |
| Normal-vs-AfricanAmerican |
5.952400E-01 |
| Normal-vs-Asian |
2.068400E-02 |
| Caucasian-vs-AfricanAmerican |
2.002400E-01 |
| Caucasian-vs-Asian |
1.097450E-01 |
| AfricanAmerican-vs-Asian |
2.460300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.027610E-01 |
| Normal-vs-Female |
9.776000E-02 |
| Male-vs-Female |
7.143000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.978000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.508200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.176160E-01 |
| Normal-vs-Age(81-100Yrs) |
7.718000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.651400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.549200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.287600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.608800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.918800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.561800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.406200E-01 |
| Classical-VS-Follicular |
6.790300E-04 |
| Classical-VS-Other |
5.059000E-01 |
| Classical-VS-Normal |
5.871200E-01 |
| Tall-VS-Follicular |
3.675800E-01 |
| Tall-VS-Other |
9.546200E-01 |
| Tall-VS-Normal |
1.374420E-01 |
| Follicular-VS-Other |
6.607800E-01 |
| Follicular-VS-Normal |
3.404000E-03 |
| Other-VS-Normal |
3.263800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.462180E-02 |
| Normal-vs-N1 |
4.037600E-03 |
| N0-vs-N1 |
3.512200E-01 |
|
|
